Liminal BioSciences LMNL

Quarterly report 2022-Q2
added 08-10-2022

Liminal BioSciences DIO Ratio 2011-2026 | LMNL

Annual DIO Ratio Liminal BioSciences

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	1.68 K	995	171	1.3 K	738	244	135	166	82.2	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.68 K	82.2	612

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Alnylam Pharmaceuticals ALNY	43.5	$ 327.75	-1.69 %	$ 42.9 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 21.62	-0.28 %	$ 1.01 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Akebia Therapeutics AKBA	147	$ 1.41	-9.03 %	$ 363 M	USA
	Aquestive Therapeutics AQST	120	$ 4.18	-1.5 %	$ 447 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 24.23	-1.42 %	$ 3.08 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Grifols, S.A. GRFS	0.000171	$ 8.68	-0.12 %	$ 6.83 B	Spain
	Autolus Therapeutics plc AUTL	70.7	$ 1.48	-0.67 %	$ 394 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Caladrius Biosciences CLBS	35.8	-	-16.75 %	$ 25.8 M	USA
	bluebird bio BLUE	125	-	-	$ 546 M	USA